P16-immunocytochemistry in the interpretation of HPV-associated cellmutations of the vagina - a casestudy

被引:0
|
作者
Reich, O. [1 ]
机构
[1] Univ Frauenklin Graz, Abt Gynakol, Graz, Austria
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
19
引用
收藏
页码:268 / 269
页数:2
相关论文
共 50 条
  • [21] Evaluation of Performance of p16 Immunostaining in Cell-Blocks for the Detection of Recurrence in HPV-Associated Cervical Malignancies
    Hummel, Kelsey
    Xu, Ya
    Masand, Ramya
    LABORATORY INVESTIGATION, 2023, 103 (03) : S315 - S316
  • [22] Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
    Schulte, Jefree J.
    Steinmetz, Jamie
    Furtado, Larissa, V
    Husain, Aliya N.
    Lingen, Mark W.
    Cipriani, Nicole A.
    HEAD & NECK PATHOLOGY, 2020, 14 (04): : 966 - 973
  • [23] Use of Human Papillomavirus 16 (HPV16) Cell Free DNA for Assessment of Response to Chemoradiation in HPV-Associated Oropharyngeal Cancer
    Higginson, D. S.
    Scher, E. D.
    Yarusi, B.
    Chan, S.
    Mitrani, L.
    Thompson, C.
    Cleary, C. R.
    McBride, S. M.
    Riaz, N.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S78 - S79
  • [24] Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project
    Lassen, Pernille
    Lacas, Benjamin
    Pignon, Jean-Pierre
    Trotti, Andy
    Zackrisson, Bjorn
    Zhang, Qiang
    Overgaard, Jens
    Blanchard, Pierre
    RADIOTHERAPY AND ONCOLOGY, 2018, 126 (01) : 107 - 115
  • [25] Phase I/IIa study of therapeutic p16INK4a vaccination in patients with HPV-associated cancers.
    Reuschenbach, Miriam
    Rafiyan, Mohammad-Reza
    Karbach, Julia
    Pauligk, Claudia
    Faulstich, Franziska
    Sauer, Madeleine
    Prigge, Elena-Sophie
    Kloor, Matthias
    Al-Batran, Salah-Eddin
    Kaufmann, Andreas M.
    Schneider, Achim
    Jaeger, Elke
    Doeberitz, Magnus von Knebel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia
    Walts, Ann E.
    Lechago, Juan
    Bose, Shikha
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) : 795 - 801
  • [27] A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression
    S. A. Rasmussen
    J. S. Lewis
    L. Mirabello
    S. Bass
    M. Yeager
    M. J. Corsten
    M. J. Bullock
    Head and Neck Pathology, 2022, 16 : 1251 - 1256
  • [28] A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression
    Rasmussen, S. A.
    Lewis, J. S., Jr.
    Mirabello, L.
    Bass, S.
    Yeager, M.
    Corsten, M. J.
    Bullock, M. J.
    HEAD & NECK PATHOLOGY, 2022, 16 (04): : 1251 - 1256
  • [29] HPV-associated p16 positive head and neck squamous cell carcinomas exhibit improved prognosis and response to radiotherapy
    Lassen, P.
    Eriksen, J.
    Alsner, J.
    Hamilton-Dutoit, S.
    Overgaard, J.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S4 - S4
  • [30] Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
    Aggarwal, Charu
    Cohen, Roger B.
    Morrow, Matthew P.
    Kraynyak, Kimberly A.
    Sylvester, Albert J.
    Knoblock, Dawson M.
    Bauml, Joshua M.
    Weinstein, Gregory S.
    Lin, Alexander
    Boyer, Jean
    Sakata, Lindsay
    Tan, Sophie
    Anton, Aubrey
    Dickerson, Kelsie
    Mangrolia, Drishty
    Vang, Russell
    Dallas, Michael
    Oyola, Sandra
    Duff, Susan
    Esser, Mark
    Kumar, Rakesh
    Weiner, David
    Csiki, Ildiko
    Bagarazzi, Mark L.
    CLINICAL CANCER RESEARCH, 2019, 25 (01) : 110 - 124